Leading Surgeon Specializing in Breast Preservation During Cancer Treatment Shares Latest Developments in the Field
Dr. Rhonda WachsmuthImage courtesy of Breast Cancer Surgery
With over 2 decades of surgical experience, Dr. Rhonda Wachsmuth leads an all-woman practice, maintaining a crisp focus on breast disease. She has pioneered many of the treatments that have dramatically reduced the need for invasive breast surgeries.
“I’ve been through most of the major changes over the last 20 years,” said Dr. Wachsmuth. “Everything that’s happened has followed a route of less and less surgery, and that makes this an exciting time...
MarginProbe Helps New Mexico Breast Cancer Surgeon Ensure Clear Margins for IORT
Calvin Ridgeway, M.D. Image courtesy of Lovelace Medical Group
Calvin Ridgeway, M.D., is a surgical oncologist specializing in breast cancer care. He began his career as a surgical oncologist for the United States Air force at Kirtland Air Force Base in Albuquerque and in 2008 joined Lovelace Women’s Hospital to start their breast care center - the first accredited in New Mexico. After treating breast cancer for 20 years, Dr. Ridgeway admits there have been many changes in breast cancer...
Dune Medical Names Seasoned Radio Frequency Expert Avihai Lachman as Vice President of Research and Development
June 12, 2018 (Alpharetta, Ga.) Dune Medical Devices has appointed Avihai Lachman as Vice President of Research and Development, leading the company’s effort in expanding the use of Radio Frequency (RF) Spectroscopy for new clinical applications and disease sites.
Lachman joins Dune after more than a decade of developing radio frequency technologies. He spent the past 18 years with Gilat Satellite Networks developing digital communication algorithms for satellite modems and tracking antenna systems mainly for the in-flight connectivity market. Lachman...
Dune Medical to Present at Jefferies 2018 Global Healthcare Conference
Medtech Innovator Dune Medical Devices to present at Jefferies 2018 Global Healthcare Conference
ATLANTA, Ga -
-Lori Chmura, CEO of Dune Medical Devices, maker of the successful MarginProbe device, will address investors at the Jefferies Global Healthcare Conference on June 8th, 12.30 ET. The presentation will also be available as a webcast at dunemedical.com/investors. Lori Chmura and Alan Bond, CFO will be available for appointments in New York on June 7th and 8th both before and after the presentation.
Dune Medical Devices is a...
Dune Medical & CEO Lori Chmura Named 2018 Health Care Heroes Finalist by the Atlanta Business Chronicle
The Atlanta Business Chronicle has named Dune Medical Device’s Lori Chmura as a finalist for Health Care Innovator/Researcher in their 2018 Health Care Heroes Awards. These awards aim to highlight the individuals and companies that are dedicated to improving the overall health and well-being of the community. This is the publication’s 21st year holding the Health Care Heroes Awards.
The awards include five categories - Lifetime Achievement, Physician/Physician Group, Health Care Researcher/Innovator, Allied Health Professional and Rising Star. All of...